Qcm Cayman, Ltd. Teva Pharmaceutical Industries LTD Transaction History

Qcm Cayman, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$8.38 - $10.18 $97,451 - $118,383	-11,629 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$9.9 - $11.56 $115,127 - $134,431	11,629 New	11,629 $115,000
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $162,524 - $201,347	-15,718 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $25,322 - $32,468	2,941 Added 23.02%	15,718 $152,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $109,498 - $162,140	12,777 New	12,777 $115,000
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $221,514 - $326,394	-13,209 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $220,326 - $291,522	13,209 New	13,209 $226,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.